Ownership history in ALGERT GLOBAL LLC · 10 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in VANDA PHARMACEUTICALS INC COM (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 34,934 | +8,024 | +29.8% | 0.00% | $174K | $4.99 |
| 2025 Q1 | ADDED | 26,910 | +15,080 | +127.5% | 0.00% | $124K | $4.59 |
| 2022 Q3 | REDUCED | 11,830 | -64,374 | -84.5% | 0.01% | $117K | $9.88 |
| 2018 Q4 | ADDED | 76,204 | +57,981 | +318.2% | 0.56% | $2.0M | $26.13 |
| 2017 Q1 | ADDED | 18,223 | +1,927 | +11.8% | 0.07% | $255K | $14.00 |
| 2016 Q4 | REDUCED | 16,296 | -10,437 | -39.0% | 0.07% | $260K | $15.95 |
| 2013 Q3 | REDUCED | 26,733 | -139,901 | -84.0% | 0.08% | $293K | $10.95 |
| 2013 Q2 | REDUCED | 166,634 | -32,803 | -16.4% | 0.42% | $1.3M | $8.08 |
| 2013 Q1 | ADDED | 199,437 | +178,277 | +842.5% | 0.25% | $782K | $3.92 |
| 2012 Q4 | INITIATED | 21,160 | — | — | 0.02% | $78K | $3.70 |
As of 2025 Q4 — sorted by position size